Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against Jiangbo Pharmaceuticals, Inc. (NASDAQ: JGBO)
(firmenpresse) - OKLAHOMA CITY, OK -- (Marketwire) -- 07/19/11 -- On July 15, 2011, a class action lawsuit was filed in the United States District Court for the Southern District of Florida against Jiangbo Pharmaceuticals, Inc. (NASDAQ: JGBO). The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material misrepresentations to the market which had the effect of artificially inflating the market price. The class period is from May 17, 2010 through May 31, 2011.
Plaintiff seeks to recover damages on behalf of the Class. If you are a member of the Class as described above, you may move the Court no later than Wednesday, September 14, 2011, to serve as a lead plaintiff for the Class. However, in order to do so, you must meet certain legal requirements pursuant to the Private Securities Litigation Reform Act of 1995.
If you wish to discuss this action, participate in this or any other lawsuit, or have any questions or concerns regarding this notice, or preservation of your rights, please contact:
William B. Federman
FEDERMAN & SHERWOOD
10205 North Pennsylvania Avenue
Oklahoma City, OK 73120
(405) 235-1560
Email to:
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 19.07.2011 - 22:21 Uhr
Sprache: Deutsch
News-ID 36082
Anzahl Zeichen: 0
contact information:
Town:
OKLAHOMA CITY, OK
Kategorie:
Legal
Diese Pressemitteilung wurde bisher 258 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against Jiangbo Pharmaceuticals, Inc. (NASDAQ: JGBO)"
steht unter der journalistisch-redaktionellen Verantwortung von
Federman & amp; Sherwood (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
